HER3 is a member of the epidermal growth factor receptor (EGFR) family (EGFR, HER2, HER3 and HER4) and has been implicated in tumor initiation, progression and resistance, a major contributor to treatment failure [2, 3]. Here, EGFR is linked to neoplasm.